(SMMU) |
| 0 (0%) 05-29 17:13 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 59.01 |
| Resistance 1: | 50.52 |
| Pivot price: | 50.37 |
| Support 1: | 50.33 |
| Support 2: | 50.22 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 26 May 2026
Responsive Playbooks and the SMMU Inflection - Stock Traders Daily
Tue, 28 Apr 2026
8x NVIDIA GB10 SMMU Performance With NCCL Scaling - ServeTheHome
Wed, 11 Mar 2026
Massive Device-Related Thrombus After Left Atrial Appendage Closure in Kidney Transplant Recipient With Hypertrophic Cardiomyopathy - JACC Journals
Wed, 04 Mar 2026
The release of OSCE SMM staff members is a prerequisite for the implementation of ceasefire monitoring - Центр прав людини ZMINA
Fri, 09 Jan 2026
CRISPLD2 Attenuates Intervertebral Disc Degeneration by Suppressing Oxidative Stress-Induced Ferroptosis through the miR-548I-IL17A Axis - Wiley
Thu, 18 Dec 2025
Advances in external therapies of traditional Chinese medicine for the management of hyperuricemia: a comprehensive review - Frontiers
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
